Kennedy Hodges, LLP Is Revewing Whistle-Blower Cases

Kennedy Hodges is reviewing cases involving the False Claims Act (Qui Tam), a 146 year old federal law that often ensnares health care providers and drug manufacturers. The pharmaceutical industry has been a popular target of whistle blowers in recent years. Accordingly, Kennedy Hodges is reviewing cases involving pharmaceutical sales in addition to individuals and institutions who seek reimbursements for health care, medical devices, testing, etc.

Because the government is paying more for individual health care - through Medicare, Medicaid, the VA - there are more false claims being made involving the health care industry. Accordingly, doctors, hospitals, drug makers, device makers and other health care providers are increasingly becoming the target of Qui Tam actions. However, our firm's inquiry is not limited to the medical industry as we are also seeking cases involving government contracts, including defense contracts.

Whistle blowers usually receive from 10 to 30 percent of the recovery due to the federal government. In many cases, a whistle blower can receive tens of millions of dollars from a single Qui Tam action.

If you are looking for a Houston Qui Tam attorney or a Houston False Claims Act attorney, please contact us . We will also review cases originating outside Texas and throughout the United States.